Anti-MARCKS (phospho S158) antibody [EP2113Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal MARCKS phospho S158 antibody. Suitable for WB and reacts with Rat, Human, Mouse samples. Cited in 10 publications.
View Alternative Names
MACS, PRKCSL, MARCKS, Myristoylated alanine-rich C-kinase substrate, 80K-L protein, PKCSL
- WB
Supplier Data
Western blot - Anti-MARCKS (phospho S158) antibody [EP2113Y] (AB81295)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-MARCKS (phospho S158) antibody [EP2113Y] (ab81295) at 1/10000 dilution
Lane 1:
HEK293 cells treated with TPA at 10 µg
Lane 2:
HEK293 cells treated with TPA, and the PVDF membrane treated with lambda phosphatase at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 32 kDa
Observed band size: 87 kDa
false
- WB
Unknown
Western blot - Anti-MARCKS (phospho S158) antibody [EP2113Y] (AB81295)
All lanes:
Western blot - Anti-MARCKS (phospho S158) antibody [EP2113Y] (ab81295) at 1/2000 dilution
Lane 1:
Hela cell lysates, untreated. at 10 µg
Lane 2:
Hela cell lysates treated with TPA. at 10 µg
Secondary
All lanes:
HRP labelled goat anti rabbit at 1/2000 dilution
Predicted band size: 32 kDa
Observed band size: 87 kDa
false
- WB
Lab
Western blot - Anti-MARCKS (phospho S158) antibody [EP2113Y] (AB81295)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-MARCKS (phospho S158) antibody [EP2113Y] (ab81295) at 1/2000 dilution
Lane 1:
Rat brain at 10 µg
Lane 2:
Mouse brain at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 32 kDa
Observed band size: 87 kDa
false
Related conjugates and formulations (1)
-
Anti-MARCKS (phospho S158) antibody [EP2113Y] - BSA and Azide free
Reactivity data
Product details
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in physiology 13:815301 PubMed35418879
2022
Applications
Unspecified application
Species
Unspecified reactive species
Science immunology 7:eabk2092 PubMed35119941
2022
Applications
Unspecified application
Species
Unspecified reactive species
FASEB journal : official publication of the Federa 33:14354-14369 PubMed31661644
2019
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 176:1122-1134 PubMed30706455
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 13:1216-1222 PubMed28454237
2017
Applications
WB
Species
Human
International journal of oncology 46:1079-88 PubMed25524703
2014
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of 18:3030-41 PubMed22619307
2012
Applications
WB
Species
Unspecified reactive species
British journal of cancer 104:673-84 PubMed21266973
2011
Applications
WB
Species
Human
The Journal of biological chemistry 285:18352-63 PubMed20356841
2010
Applications
Unspecified application
Species
Unspecified reactive species
Cellular signalling 22:1097-103 PubMed20211725
2010
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com